DocGo Inc (OQ:DCGO)
Business Focus: Ambulance & Emergency Services
| Sector: Healthcare | Industry: Healthcare Facilities & Services |
| See Regulatory Filings on SEC | |
| Company Contact | |
| Address: | 35 West 35th St., Floor 6 NEW YORK NY 10001 |
| Tel: | N/A |
| Website: | https://www.docgo.com |
| IR: | See website |
| Key People | ||
| Lee Bienstock Chief Executive Officer | Norman Rosenberg Chief Financial Officer | Andre Oberholzer Executive Vice President - Capital Markets and Strategy, Treasurer |
| Stephen Sugrue Chief Compliance Officer | Ely D. Tendler General Counsel, Company Secretary, Director | |
| Business Overview |
| DocGo Inc. is a healthcare transportation and mobile services company. The Company uses dispatch and communication technology to help provide healthcare transportation and mobile services in-person medical treatment directly to patients in the comfort of their homes, workplaces and other non-traditional locations, in metropolitan cities in the United States and the United Kingdom. Its segments include Transportation Services and Mobile Health Services. Its Transportation Services provides digitally enabled medical mobility solutions are offered under the Ambulnz brand. It provides clinical services, including primary and specialty care, dialysis treatments for chronic care management, and transfers between clinical settings. Its Mobile Health Services perform at home and offices, testing, vaccinations and event services, including on-site healthcare support at sporting events and concerts. Its mobile health solutions include on-site evaluation, diagnostics, triage, and treatment. |
| Financial Overview |
| For the nine months ended 30 September 2023, DocGo Inc revenues increased 28% to $425M. Net loss totaled $712K vs. income of $26.5M. Revenues reflect Mobile Health Services segment increase of 25% to $316.8M, Transportation Services segment increase of 25% to $97.2M, United States segment increase of 19% to $385.6M, United Kingdom segment increase from $9M to $39.5M. |
| Employees: | 2,064 as of Dec 31, 2022 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $545.50M as of Sep 30, 2023 |
| Annual revenue (TTM): | $533.83M as of Sep 30, 2023 |
| EBITDA (TTM): | $30.35M as of Sep 30, 2023 |
| Net annual income (TTM): | $7.35M as of Sep 30, 2023 |
| Free cash flow (TTM): | -$75.43M as of Sep 30, 2023 |
| Net Debt Last Fiscal Year: | N/A |
| Shares outstanding: | 103,896,329 as of Nov 3, 2023 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2023 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.